Staff Profile
Background
I work in partnership with academic leaders to design and facilitate bespoke development opportunities that support organisational change. I believe that we all contribute to shaping the organisational culture so work with colleagues to make sure all voices are heard. Building and maintaining trust is critical to this.
My previous experience in both research and teaching allows me to bring useful insights to this role. I understand that we can only function when we look after both our physical and mental wellbeing.
Publications
- Liszewski MK, Schraml B, Leung M, Caudy AA, Kemp EJ, Goodship THJ, Atkinson JP. Modeling how deficiency of membrane cofactor protein (MCP; CD46) predisposes to atypical hemolytic uremic syndrome. In: Molecular Immunology: 20th International Complement Workshop. 2004, Honolulu, Hawaii, USA: Pergamon.
- Heinen S, Sanchez-Corral P, Jackson MS, Strain L, Goodship JA, Kemp EJ, Skerka C, Jokiranta TS, Meyers K, Wagner E, Robitaille P, Esparza-Gordillo J, Rodriguez de Cordoba S, Zipfel PF, Goodship THJ. De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome. Human Mutation 2006, 27(3), 292-293.
- Goodship THJ, Liszewski MK, Kemp EJ, Richards A, Atkinson JP. Mutations in CD46, a complement regulatory protein, predispose to atypical HUS. Trends in Molecular Medicine 2004, 10(5), 226-231.
- Kavanagh D, Kemp EJ, Mayland E, Winney RJ, Duffield JS, Warwick G, Richards A, Ward R, Goodship JA, Goodship THJ. Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome. Journal of the American Society of Nephrology 2005, 16(7), 2150-2155.